Skip to main content
TipRanks
Go Ultimate75% OFF

Alterity Therapeutics (ATH) Stock Statistics & Valuation Metrics

40 Followers

Total Valuation

Alterity Therapeutics has a market cap or net worth of AUD 57.29M. The enterprise value is AUD 32.34M.

Market Cap
AUD 57.29M
Enterprise Value
AUD 32.34M

Share Statistics

Alterity Therapeutics has 229,150,850 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
229,150,850
Owned by Insiders
0.10%
Owned by Institutions
―

Financial Efficiency

Alterity Therapeutics’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -57.61%.

Return on Equity (ROE)
-0.55
Return on Assets (ROA)
-0.51
Return on Invested Capital (ROIC)
-57.61%
Return on Capital Employed (ROCE)
-0.66
Revenue Per Employee
0
Profits Per Employee
-2.13M
Employee Count
11
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Alterity Therapeutics is -2.26. Alterity Therapeutics’s PEG ratio is 0.13.

PE Ratio
-2.26
PS Ratio
0.00
PB Ratio
1.27
Price to FCF
-42.53
Price to Operating Cash Flow
-4.11
PEG Ratio
0.13

Income Statement

In the last 12 months, Alterity Therapeutics had revenue of 0 and earned -23.40M in profits. Earnings per share was -0.11.

Revenue
0
Gross Profit
-115.54K
Operating Income
-28.42M
Pretax Income
-26.90M
Net Income
-23.40M
EBITDA
-28.30M
Earnings Per Share (EPS)
-0.11

Cash Flow

In the last 12 months, operating cash flow was -22.52M and capital expenditures 22.52M, giving a free cash flow of 0 billion.

Operating Cash Flow
-22.52M
Free Cash Flow
0
Free Cash Flow per Share
-0.01

Dividends & Yields

Alterity Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.35%
Earnings Yield
-43.03%

Stock Price Statistics

Beta
1.76
52-Week Price Change
-50.00%
50-Day Moving Average
0.35
200-Day Moving Average
0.47
Relative Strength Index (RSI)
39.52
Average Volume (3m)
356.35K

Important Dates

Alterity Therapeutics upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date
Feb 25, 2026
Next Earnings Date
Mar 04, 2027
Ex-Dividend Date
―

Financial Position

Alterity Therapeutics as a current ratio of 14.52, with Debt / Equity ratio of 0.45%

Current Ratio
14.52
Quick Ratio
14.52
Debt to Market Cap
0.00
Net Debt to EBITDA
1.31
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Alterity Therapeutics has paid -3.50M in taxes.

Income Tax
-3.50M
Effective Tax Rate
0.13

Enterprise Valuation

Alterity Therapeutics EV to EBITDA ratio is -0.71, with an EV/FCF ratio of -14.97.

EV to Sales
0.00
EV to EBITDA
-0.71
EV to Free Cash Flow
-14.97
EV to Operating Cash Flow
-1.52

Balance Sheet

Alterity Therapeutics has AUD 37.32M in cash and marketable securities with AUD 193.47K in debt, giving a net cash position of AUD 37.12M billion.

Cash & Marketable Securities
AUD 37.32M
Total Debt
AUD 193.47K
Net Cash
AUD 37.12M
Net Cash Per Share
AUD 0.16
Tangible Book Value Per Share
AUD 0.20

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Alterity Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
-16.21%

Scores

Smart Score
5
AI Score
42